Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
NOT YET RECRUITING
NCT06719934
PHASE1
Ttt of Adenomyosis
Sponsor: Al-Azhar University
View on ClinicalTrials.gov
Summary
to evaluate use of Dienogest versus uterine arteries embolization in treatment of Adenomyosis-associated symptoms as dysmenorrhea, heavy menstrual bleeding and bulk-related symptoms
Official title: Dienogest Versus Uterine Artery Embolization in Ttt of Adenomyosis -cohort Comparetive Study
Key Details
Gender
FEMALE
Age Range
30 Years - 50 Years
Study Type
INTERVENTIONAL
Enrollment
100
Start Date
2025-01-01
Completion Date
2026-01-01
Last Updated
2024-12-06
Healthy Volunteers
No
Conditions
Interventions
DRUG
Dienogest 2 mg orally
2 mg Dienogest orally
PROCEDURE
UAE
under local anasthesia uterine artery embolizationwill be done
Locations (1)
Al Azhar university
Asyut, Assuit, Egypt